Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
This study has been completed.
Study NCT00957372 Information provided by Bial - Portela C S.A.
First Received on August 10, 2009. Last Updated on August 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
placebo (Part I)
Sponsors listed in this trial
Bial - Portela C S.A.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers